Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1787025
Name of medicinal product: Avishield IB GI-13
Active substances:
Avian infectious bronchitis virus vaccine
Estonian, English, Latin
ATC code: QI01AD07
Dosage form: lyophilisate for oculonasal suspension/use in drinking water
Route of administration: in drinking water use; oculonasal use
Strengh:  
Amount in package: 1000annust 10TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: For the active immunisation of chickens in order to reduce the detrimental effect on the ciliary activity resulting from infection by avian infectious bronchitis virus, serotype 793B (GI-13 lineage), which may be manifested in respiratory clinical signs. Onset of immunity: 10 days after vaccination. Duration of immunity: 56 days after vaccination.
Safety features: No
Summary of product characteristics (SPC):  (last updated March 31, 2022)
Package information leaflet (PIL): EST  (last updated March 31, 2022)
Labelling:  (last updated March 31, 2022)
Withdrawal time: 0 päeva.
Species: kana
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Genera d.d. 
Marketing authorization number: 2229 
Marketing authorization issued on: March 31, 2020 
Marketing authorization expires on: March 31, 2025 
Marketing authorization procedure type: Decentralised 
Entry/Changing date: March 31, 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere